Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Combinatorial Gene Control

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Variant analysis and biochemical investigation in two siblings with late onset idiopathic secondary erythrocytosis: A case report.

Medicine·2025

Same author

Clinical, dermoscopic and confocal microscopy features of multiple primary melanomas according to pathogenic germline variant status: a retrospective, hospital-based study.

Clinical and experimental dermatology·2025

Same author

Is immunotherapy safe and effective in patients with VEXAS syndrome?

Journal for immunotherapy of cancer·2025

Same author

Thoracic Giant Venous Malformation in a Stillbirth with <i>Pik3ca</i> Somatic Mutation.

Fetal and pediatric pathology·2025

Same author

A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures.

Cancers·2025

Same author

Clinical exome next‑generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosis.

Experimental and therapeutic medicine·2025

Search research articles

Related Experiment Video

Updated: Sep 10, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

circRNA/miRNA Networks Regulate KLF4 in Tumor Development.

Raffaele Frazzi¹, Enrico Farnetti¹, Davide Nicoli¹

¹Molecular Pathology Laboratory, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

|August 27, 2025

Summary

Circular RNAs and miRNAs form novel regulatory axes impacting Krüppel-like factor 4 (KLF4) in cancer. These RNA interactions offer new therapeutic targets for various malignancies.

Keywords:

KLF4 circRNAs epigenetic regulation

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Experiment Videos

Last Updated: Sep 10, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Area of Science:

Epigenetics
Molecular Biology
Oncology

Background:

Krüppel-like factor 4 (KLF4) is epigenetically regulated and implicated in cell reprogramming and cancer.
KLF4 expression correlates with tumor invasiveness and prognosis in a tissue-specific manner.
KLF4 plays a role in diverse and prevalent human cancers.

Purpose of the Study:

To investigate the interplay between circular RNAs (circRNAs), microRNAs (miRNAs), and KLF4 in cancer.
To elucidate the regulatory mechanisms involving circRNA/miRNA/KLF4 axes.

Main Methods:

Literature search on PubMed using keywords 'miRNA and KLF4 and cancer' (last 5 years) and 'circRNA and KLF4' (2013-2024).
Selection of relevant oncological publications.

Main Results:

Identification of circRNA/miRNA axes that regulate KLF4 expression.
circRNAs function as miRNA sponges, influencing KLF4 activity.
KLF4 exhibits context-dependent roles as a tumor promoter or suppressor.

Conclusions:

circRNA/miRNA/KLF4 axes represent a novel layer of epigenetic regulation in cancer.
These RNA-based modulators explain KLF4's complex regulation.
This axis presents potential for new therapeutic strategies targeting cancer.